Anna Dahlman is an accomplished professional in non-clinical safety and toxicology with extensive experience in the biopharmaceutical industry. Currently serving as Director of Non-Clinical Safety & Toxicology at Genmab since October 2019, Anna develops and executes safety evaluation strategies and oversees the design and reporting of nonclinical studies. Prior roles include Senior Scientist at Alligator Bioscience AB, where responsibilities encompassed managing nonclinical studies in immuno-oncology and supporting successful clinical trial applications. Anna's career began with a PhD in Medical Sciences from Lund University, complemented by a robust foundation in biology and medicine. Anna's expertise spans preclinical research, therapeutic antibody development, and the publication of significant findings in palliative care.
This person is not in the org chart
This person is not in any teams
This person is not in any offices